Intervention Review

Risperidone versus olanzapine for schizophrenia

  1. Mahesh B Jayaram1,*,
  2. Prakash Hosalli2,
  3. T S Stroup3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 9 JAN 2006

DOI: 10.1002/14651858.CD005237.pub2

Database Title

Additional Information

How to Cite

Jayaram MB, Hosalli P, Stroup TS. Risperidone versus olanzapine for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005237. DOI: 10.1002/14651858.CD005237.pub2.

Author Information

  1. 1

    Leeds Partnership Foundation NHS Trust, CMHT, Leeds, UK

  2. 2

    Seacroft Hospital, The Newsam Centre, Leeds, West Yorkshire, UK

  3. 3

    Division of Mental Health Services & Policy Research, New York State Psychiatric Institute, Psychiatry, New York, New York, USA

*Mahesh B Jayaram, CMHT, Leeds Partnership Foundation NHS Trust, Bridge House, Balm Road, Leeds, LS10 2TP, UK. maheshbj@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 MAR 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (597K)Full (1061K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Summary (59K)Standard (597K)Full (1061K)